期刊文献+

使用SPIO对大鼠肝癌模型进行MR增强显像的实验研究 被引量:2

Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats
下载PDF
导出
摘要 目的评价超顺磁氧化铁(SPIO)增强MR成像对肝脏占位性病变的诊断价值。方法制作20只大鼠肝癌模型,注射SPIO前后行MR扫描,扫描序列包括SE T1WI(390 ms/14 ms)、TSE T2WI(4 100 ms/99 ms)、SE PDWI和T2WI(1 800 ms/20 ms/70 ms)、FLASH T2*WI(600 ms/15 ms/15°)、FLASH T1WI(150 ms/14 ms/70°),分析不同病灶的强化特点。5只正常大鼠作为空白对照,扫描序列与实验组相同。结果注射SPIO后,正常肝组织和硬化肝组织的信号强度都下降,以GRE T2*WI最为显著。SPIO增强T1WI上,肝细胞癌、肝硬化再生结节、灶性结节增生都出现阳性强化;T2WI上,肝细胞癌仍保持较高的信号强度,而再生结节、灶性结节增生出现负性强化现象。SPIO增强后GRE T2*WI中,肝细胞癌的增强噪声比高于其他扫描序列,TSE和SE T2WI在显示肝细胞癌的信噪比、增强噪声比方面没有显著性差异。结论SPIO对比剂在T1、T2WI的强化特性有助于肝脏占位性病变的显示,对于良、恶性结节的定性诊断有着重要意义。 Objective To evaluate the value of superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging in the diagnoses of focal liver lesions. Methods Twenty rat models of hepatocellular carcinoma were induced by feeding the rats with N-nitrosodiethylamine. Before and after SPIO injection into the rats, MR imaging was performed including the sequences of spin-echo (SE) T1WI (390 ms/14 ms), TSE T2WI (4 100 ms/99 ms), SE Dual-echoes (1 800 ms/20 ms/70 ms), GRE FLASH T2*WI (600 ms/15 ms/15°), and GRE FLASH T1WI (150 ms/14 ms/70°). Another 5 normal rats were selected as negative control, which also received SPIO and MR imaging in the same manner as described above. The characteristics of SPIO-enhanced MRI of different liver lesions were analyzed. Results After SPIO enhancement, the signal intensity of normal liver and cirrhotic liver both decreased, especially on GRE T2*WI. The signal intensity of hepatocellular carcinoma (HCC), regenerative nodules (RN), and focal nodule hyperplasia (FNH) all increased on T1WI images. On T2WI and T2*-weighted images, the signal intensity of HCC remained high, while significant signal loss occurred in RN and FNH. After SPIO administration, the contrast-to-noise (CNR) of HCC on GRE T2*-weighted images was greater than that of other sequences. Conclusions SPIO has not only considerable T2-negative effect but also slightly T1-shortening effect, which is of great value in the differential diagnosis of focal liver lesions.
出处 《第一军医大学学报》 CSCD 北大核心 2002年第12期1061-1065,共5页 Journal of First Military Medical University
基金 国家重点科技项目(96-901-05-10)
关键词 肝癌 肝脏肿瘤 磁共振成像 超顺磁氧化铁 对比剂 增强效应 carcinoma, hepatic magnetic resonance imaging superparamagnetic iron oxide contrast agent enhancement effect
  • 相关文献

参考文献15

  • 1Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR Imaging of liver and spleen: first experience in human with a new superpara magnetic iron oxide [J]. J Magn Reson Imaging, 1994, 4 (5): 659-68.
  • 2Van Beers B, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver[J]. Radiology, 1997, 203(2): 297-306.
  • 3Oudkerk M, Van Den Heuvel AG, Wielopolski PA, et al. Hepatic le sions: detection with Ferumoxide-enhanced T1-weighted MR imaging[J]. Radiology, 1997, 203 (2): 449-56.
  • 4Mayo-Smith W, Saini S, Slater G, et al. MR contrast material for vascular enhancement: value ofsuperparamagnetic iron oxide [J].Am J Roentgenol, 1996, 166 (1): 73-7.
  • 5Van Gansbeke D, Metens TM, Matos C, et al. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization [ J ]. J Magn Resont Imaging, 1997, 7 (3): 482-9.
  • 6Shamsi K, Balzer T, Saini S, et al. Superparamagnetic iron oxide panicles (SH U 555A): evaluation of efficacy in three doses for hep atic MR imaging[J]. Radiology, 1998, 206 (2): 365-71.
  • 7刘爱连,郎志谨,付维利,孙萌.SD大鼠肝癌模型的MRI征象与病理对照研究[J].中国医学计算机成像杂志,1999,5(1):33-36. 被引量:10
  • 8文 戈,张雪林,昌仁民,夏 琼,苍 鹏,张 英.超顺磁性氧化铁增强MRI在肝脏局灶性病变诊断中的应用[J].第一军医大学学报,2002,22(5):451-452. 被引量:7
  • 9Mutakami T, Kuroda C, Marukawa T, et al. Regenerating nodules of hepatic cirrhosis: MR findings with pathologic correlation [J]. Am J Roentgenol, 1990, 154 (3): 505-7.
  • 10Klimek F, Moore MA, Schneider E, et al. Histochemical and micro biochemical demonstrations of reduced pyruate kinase activity in thioacetamide-induced neoplastic nodules of rat liver [J]. Histochemistry, 1988, 90 (1): 37-42.

二级参考文献11

  • 1[1]Kondo H, Kannematsu M, Hoshi H, et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT [J]. Am J Roentgenol, 2000,174(4): 947-54.
  • 2[2]Peter F, Sanjay S. Liver-specific MR imaging contrast agents[J].Radiol Clin North Am, 1998, 36(2): 287-97.
  • 3[3]Reimer P, Tombach B. Hepatic MRI with SPIO: Detection and characterization of focal liver lesions[J]. Eur Radiol, 1998, 8(7): 1198-204.
  • 4[4]Poeckler SC, Koepke J, Gnckel F, et al. MRI with superparamagnetic iron oxide: Efficacy in the detection and characterization of focal hepatic lesions[J]. Magn Reson Imaging, 1999, 17(3): 383-92.
  • 5[5]Grangier C, Toumiaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles[J]. J Comput Assist Tomogr, 1994, 18(6): 888-96.
  • 6[6]Oudkerk M, van-den-Heuvel AG, Wielopolski PA, et al. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging[J]. Radiology, 1997, 203(2): 449-56.
  • 7[7]Lencioni R, Donati F, Cioni D, et al. Detection of colorectal liver metastases: prospective comparison ofunenhanced and ferumoxidesenhanced magnetc resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography[ J]. MAGMA, 1998, 7(2): 76-87.
  • 8刘爱连,中华放射学杂志,1997年,31卷,491页
  • 9刘爱连,实用放射学杂志,1995年,11卷,276页
  • 10程红岩,中华放射学杂志,1994年,28卷,159页

共引文献15

同被引文献11

  • 1Lee JM, Kim CS, Youk JH. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging[J]. Korean J Radiol,2003,4(1):9-18.
  • 2Vogl TJ, Schwarz W, Blume S. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US[J]. Eur Radiol,2003,13(2):262-272.
  • 3Hahn PF, Saini S. Liver-specific MR imaging contrast agents[J]. Radiol Clin North Am,1998,36(2):287-297.
  • 4Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions[J]. Eur Radiol,1998,8(7):1198-1204.
  • 5Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions[J]. Radiology,1995,196(2):481-488.
  • 6Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography[J]. Radiology,1996,200(3):785-792.
  • 7Kim YK, Kim CS, Lee YH. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas[J]. AJR,2004,182(5):1217-1223.
  • 8Takahama K, Amano Y, Hayashi H. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging[J]. Abdom Imaging, 2003,28(4):525-530.
  • 9Kwak HS, Lee JM, Kim CS. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography[J]. Eur Radiol,2004,14(3):447-457.
  • 10王莉,田建明,陆建平,王飞,刘崎,曾浩,陈爱华,金爱国,龚建国,郝强,袁敏,陶文照.大鼠种植型肝癌的超顺磁性氧化铁磁共振增强实验研究[J].中华放射学杂志,2000,34(12):805-810. 被引量:10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部